Quick Summary

Fenugreek (Trigonella foenum-graecum) is a traditionally used medicinal plant primarily studied for its potential effects on glycemic control and lipid profiles, especially in type 2 diabetes mellitus (T2DM). Meta-analyses of randomized controlled trials (RCTs) suggest fenugreek supplementation may help improve fasting blood glucose, postprandial glucose, HbA1c, insulin levels, and certain lipid parameters. There is limited evidence for benefits in metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) when combined with lifestyle interventions. Despite promising preliminary clinical findings, further high-quality, large-scale human studies are needed to confirm efficacy and safety.

What is it?

Fenugreek is an annual herb native to the Mediterranean region and western Asia. Its seeds and leaves have been used in culinary and traditional medicine practices for centuries. The species name is Trigonella foenum-graecum. Fenugreek seeds are rich in fiber, proteins, and various bioactive compounds.

Traditional Uses

Traditionally, fenugreek has been used to support digestive health, stimulate milk production in breastfeeding women, reduce inflammation, and aid blood sugar control. It has also been applied as a spice in cooking and as a herbal remedy for various metabolic and gastrointestinal conditions.

Active Compounds

Fenugreek seeds contain several active compounds including:

  • Galactomannans (soluble fibers)
  • Saponins
  • Alkaloids such as trigonelline
  • Flavonoids and polyphenols
  • Proteins and amino acids

These bioactive components are believed to contribute to fenugreek’s pharmacological properties, particularly its effects on glucose metabolism and lipid regulation.

Potential Benefits with Evidence Levels

  • Type 2 Diabetes Mellitus (T2DM): Moderate evidence from meta-analyses of 19–26 RCTs suggests fenugreek supplementation may improve glycemic control, including reductions in fasting blood glucose, postprandial glucose, HbA1c, insulin levels, and improvements in lipid profile (total cholesterol, LDL, HDL) and BMI.

    References:
    PMID: 41509111,
    PMID: 39286181
  • Metabolic Syndrome and Lipid Profiles: Limited to moderate evidence from systematic reviews and observational studies including fenugreek as part of broader plant extract interventions show some improvements in certain lipid parameters and BMI. Effects on blood pressure and insulin resistance are inconsistent or lacking.

    References:
    PMID: 40077747,
    PMID: 41583539
  • Non-Alcoholic Fatty Liver Disease (NAFLD): Preliminary evidence from a meta-analysis of RCTs suggests fenugreek combined with lifestyle modifications may produce additive improvements in liver steatosis and liver enzyme levels compared to lifestyle changes alone.

    Reference:
    PMID: 38464716
  • Glycemic Variability in T2DM: Limited evidence from a single randomized crossover clinical trial suggests fenugreek seed flakes may reduce 24-hour glycemic variability and fasting plasma glucose. Further confirmation is required.

    Reference:
    PMID: 41038677

Side Effects

Fenugreek is generally well tolerated in clinical trials with no serious adverse effects reported. Mild and transient gastrointestinal symptoms such as bloating and gas have been occasionally noted. Long-term safety data are limited, so cautious use is advised.

Drug Interactions

There is limited information from human studies regarding fenugreek-drug interactions. Due to its potential effects on blood sugar, caution is recommended when fenugreek is used together with hypoglycemic agents, to monitor for additive blood glucose-lowering effects. No confirmed drug interactions have been reported in the available clinical studies.

Who Should Avoid It

Fenugreek should be used cautiously or avoided in individuals with known allergies to fenugreek or related plants in the Fabaceae family. Due to insufficient high-quality safety data, fenugreek is not recommended during pregnancy and breastfeeding without medical supervision.

Evidence Limitations

  • Most clinical evidence derives from short- to medium-term RCTs with varied sample sizes and methodological quality.
  • Considerable heterogeneity exists in study designs, fenugreek dosing, formulation, and outcome measures, limiting comparability.
  • Large-scale, long-duration trials are lacking for confirming sustained efficacy and safety.
  • Data on herb-drug interactions and effects in special populations, such as pregnant or breastfeeding women, are limited.
  • Some studies report high heterogeneity and inconsistent findings, necessitating cautious interpretation.
  • More research is needed to establish standardized dosing, formulations, and clinical indications.

References

Last Reviewed

June 2024

Disclaimer: This information is provided for educational purposes only and is not intended as medical advice. Fenugreek supplements may have potential effects but are not guaranteed to treat or cure any condition. Always consult a healthcare professional before starting any new herbal supplement, particularly if you have underlying health conditions or are taking medications.